Citadel Advisors - APTEVO THERAPEUTICS INC ownership

APTEVO THERAPEUTICS INC's ticker is APVO and the CUSIP is 03835L207. A total of 27 filers reported holding APTEVO THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of APTEVO THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$18,662
-80.9%
12,782
-69.6%
0.00%
Q4 2022$97,605
+91.4%
42,071
+150.8%
0.00%
Q3 2022$51,00016,7760.00%
Other shareholders
APTEVO THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 1,760,000$64,504,0009.85%
Stonepine Capital Management, LLC 18,280$670,0000.51%
Ghost Tree Capital, LLC 50,000$1,833,0000.41%
Anson Funds Management LP 45,462$1,666,0000.34%
RTW INVESTMENTS, LP 288,236$10,564,0000.18%
Dynamic Technology Lab Private Ltd 13,202$484,0000.08%
Alyeska Investment Group, L.P. 49,601$1,818,0000.03%
BOOTHBAY FUND MANAGEMENT, LLC 11,493$421,0000.02%
PURA VIDA INVESTMENTS, LLC 8,203$301,0000.01%
Renaissance Technologies 254,423$9,325,0000.01%
View complete list of APTEVO THERAPEUTICS INC shareholders